Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The corporate-backed genetic testing service is joining forces with an NYSE-listed special purpose acquisition company sponsored by Virgin Group.

The Alphabet-backed immunotherapy developer secured nearly $588m in what was reputedly the largest ever flotation for a preclinical life sciences company.

Harvard-linked Sana brought in nearly four times as much in proceeds as originally planned and saw shares surge 40% on the first day of trading.

Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

The healthcare RPA technology developer has revealed $21.4m in funding from investors including Gradient Ventures, where founding CEO Ankit Jain used to work.

Johnson & Johnson-backed cancer biospy developer Inivata has added $35m to a series C round anchored by $25m from NeoGenomics in May.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

V-Bio Ventures, the venture firm affiliated with VIB, will focus on healthcare and sustainable agriculture companies primarily in Belgium.

Hewlett Packard Enterprise and Novartis dRx Capital helped the data management technology developer secure funding that will support product development.